Proposed S.B. No. 439
Session Year 2025


AN ACT REQUIRING MEDICAID COVERAGE FOR BONE MARROW AND STEM CELL TRANSPLANTS AND FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE.

To provide equitable access to life-changing medical advancements to treat sickle cell disease, ameliorate suffering and reduce long-term health care costs.


Other Bills with Similar Topics

  Health insurance 

 

  Medicaid 

 

  Sickle cell disease 

  Stem cell research